However, T cells from allogeneic sources may present a risk of graft‐versus‐host disease (GVHD) due to the mismatch between the TCR of donor T cells and the recipient's MHC molecules, leading to unwanted cytotoxicity against normal tissue. This evidence concerns the gene HLA-C and graft versus host disease.